PDT Partners’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-69,391
| Closed | -$110K | – | 533 |
|
|
2018
Q4 | $110K | Sell |
69,391
-51,709
| -43% | -$82K | 0.01% | 439 |
|
|
2018
Q3 | $446K | Sell |
121,100
-26,800
| -18% | -$98.7K | 0.02% | 369 |
|
|
2018
Q2 | $419K | Sell |
147,900
-74,600
| -34% | -$211K | 0.02% | 413 |
|
|
2018
Q1 | $825K | Buy |
+222,500
| New | +$825K | 0.03% | 378 |
|
|
2017
Q4 | – | Sell |
-216,000
| Closed | -$970K | – | 586 |
|
|
2017
Q3 | $970K | Hold |
216,000
| – | – | 0.03% | 359 |
|
|
2017
Q2 | $991K | Sell |
216,000
-72,000
| -25% | -$330K | 0.04% | 339 |
|
|
2017
Q1 | $1.21M | Buy |
288,000
+88,569
| +44% | +$373K | 0.06% | 295 |
|
|
2016
Q4 | $824K | Sell |
199,431
-85,469
| -30% | -$353K | 0.05% | 353 |
|
|
2016
Q3 | $2.31M | Sell |
284,900
-700
| -0.2% | -$5.67K | 0.14% | 207 |
|
|
2016
Q2 | $2.23M | Buy |
285,600
+700
| +0.2% | +$5.46K | 0.18% | 188 |
|
|
2016
Q1 | $2.2M | Buy |
284,900
+62,300
| +28% | +$481K | 0.14% | 229 |
|
|
2015
Q4 | $2.4M | Buy |
+222,600
| New | +$2.4M | 0.33% | 138 |
|
|
2015
Q2 | – | Sell |
-99,200
| Closed | -$978K | – | 1764 |
|
|
2015
Q1 | $978K | Buy |
99,200
+43,300
| +77% | +$427K | 0.02% | 795 |
|
|
2014
Q4 | $685K | Buy |
+55,900
| New | +$685K | 0.07% | 408 |
|
|
2013
Q3 | – | Sell |
-73,291
| Closed | -$600K | – | 1810 |
|
|
2013
Q2 | $600K | Buy |
+73,291
| New | +$600K | 0.01% | 996 |
|